Expected earnings - Chemomab Therapeutics Ltd.
Source: US Earnings Reports
Chemomab Therapeutics Ltd. (CMMB) is expected to report $-0.2 for Q2 2025
Chemomab Therapeutics Ltd.
NASDAQ: CMMB
CMMB Trading
-4.81% G/L:
$1.78 Last:
18,628 Volume:
$1.91 Open:
CMMB Latest News
February 17, 2026 08:00:00 am
Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference
December 02, 2025 08:00:00 am
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
November 20, 2025 08:00:00 am
Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
CMMB Stock Data
$8,046,168
4,832,891
1.89%
6
N/A
Biotechnology & Life Sciences
Healthcare
IL
Tel Aviv
